Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse

Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse

Multiple myeloma remains an incurable disease with the usual disease course requiring induction therapy, autologous stem cell transplantation for eligible patients, and long-term maintenance. Risk stratification tools and cytogenetic alterations help inform individualized therapeutic choices for pat...

Full description

Bibliographic Details
Main Authors: Parva Bhatt, Colin Kloock, Raymond Comenzo
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Current Oncology
Subjects:
relapsed/refractory
multiple myeloma
immunomodulatory agents
proteasome inhibitors
monoclonal antibodies
autologous stem cell transplant
Online Access:https://www.mdpi.com/1718-7729/30/2/179

Internet

https://www.mdpi.com/1718-7729/30/2/179

Similar Items